Mouse Genome Engineering Core Facility
小鼠基因组工程核心设施
基本信息
- 批准号:8751149
- 负责人:
- 金额:$ 4.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Animal ModelBiomedical ResearchClientComplexConsultationsCore FacilityDevelopmentDevelopmental ProcessDiseaseEmbryoEmbryo TransferEquipmentFacultyFemaleFundingFutureGenerationsGeneticGenetic EngineeringGenetically Engineered MouseGenomeGenome engineeringGenotypeGoalsHuman ResourcesIndividualInjection of therapeutic agentInstitutesInvestigationInvestmentsKnockout MiceLaboratoriesLearningMedical centerMethodsMicroinjectionsMicromanipulationMolecular BiologyMouse StrainsMusNatureNebraskaNobel PrizeOperative Surgical ProceduresPhaseProceduresRecombinantsResearchResearch PersonnelResourcesServicesSpeedStagingStudentsSystemTechniquesTechnologyTimeTrainingTraining and EducationTranscription CoactivatorTransgenesTransgenic MiceTransgenic OrganismsUnited States National Institutes of HealthUniversitiesbaseblastocystcongeniccost effectivedesignembryonic stem cellimprovedinnovationinterestmeetingsmembermodel designmouse genomemouse modelnew technologynucleasepregnantskillssuccessvector
项目摘要
As one of the important scientific cores of the Center for the Molecular Biology of Neurosensory Systems,
the goals of Mouse Genome Engineering Core facility (MGECF) are i) to serve all the needs of CoBRE
investigators related to the design and creation of transgenic and knockout mouse models, ii) undertake
technological research to continuously Improve genetic engineering methods and iii) to provide education
and training opportunities to students, researchers and faculty. MGECF was supported by CoBRE during its
Phase I at which time the facility was in the initial stages of development. By the end of Phase I the facility
was fully functional in creating the mouse models by employing standard mouse embryo manipulation
techniques such as microinjection and transferring into pseudo-pregnant females. During the CoBRE phase
II period the facility has achieved significant accomplishments: i) started offering critical services such as the
design and building of transgenic and targeting vectors that were done previously by the investigators; ii)
initiated many other services such as mouse genotyping and speed congenics; iii) acquired additional
equipment and personnel and provided training to enhance their overall skills (both scientific and
administrative); and iv) initiated research on the most advanced genome engineering methods to validate
them for offering as new services. Notably, the MGECF is among the first three such core facilities in the
nation that started offering'the genome editing service TALENs (Transcription Activator Like Effector
Nucleases). The core almost tripled its user base in 2010 and has maintained it at that level since then. It
has has successfully increased its revenue in the recent three years, becoming less dependent of CoBRE
support and demonstrating its capability to become sustainable in the future. This core facility is one of the
most critical core facilities in the region that serves many investigators across three different institutes.
Because of necessity as well as its remarkable success, the MGECF is supported by the UNMC office of the
Vice Chancellor for Research. Additionally, the VCR office has a strong commitment to provide support
beyond Phase III of CoBRE support.
作为神经感觉系统分子生物学中心的重要科学核心之一,
小鼠基因组工程核心设施(MGECF)的目标是:i)满足CoBRE的所有需求
与转基因和基因敲除小鼠模型的设计和创建相关的研究人员,ii)承担
技术研究,以不断改进基因工程方法; iii)提供教育
和培训机会的学生,研究人员和教师。MGECF得到了CoBRE的支持,
第一阶段,当时该设施正处于发展的初始阶段。到第一阶段结束时,
通过使用标准的小鼠胚胎操作,
技术,如显微注射和转移到假怀孕的女性。在CoBRE阶段
在第二阶段,该设施取得了重大成就:i)开始提供关键服务,
设计和构建转基因载体和靶向载体,这是研究人员以前完成的; ii)
启动了许多其他服务,如小鼠基因分型和速度同源性; iii)获得了额外的
设备和人员,并提供培训,以提高他们的整体技能(科学和
(四)启动最先进的基因组工程方法研究,
作为新的服务提供。值得注意的是,该基金是世界上最早的三个核心设施之一。
一个国家开始提供“基因组编辑服务TALENs(转录激活因子样效应器
核酸酶)。核心在2010年几乎将其用户基础增加了两倍,并从那时起一直保持在这一水平。它
在最近三年中,它成功地增加了收入,减少了对Cobre的依赖
支持并展示其未来可持续发展的能力。这个核心设施是
该区域最重要的核心设施,为三个不同研究所的许多研究人员提供服务。
由于必要性以及其显著的成功,MGECF得到了联合国MC办公室的支持,
副校长研究。此外,VCR办公室有一个强有力的承诺,提供支持
第三阶段的CoBRE支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Channabasavaiah Gurumurthy其他文献
Channabasavaiah Gurumurthy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Channabasavaiah Gurumurthy', 18)}}的其他基金
Development of humanized transgenic mice for HBV/HIV co-infection studies
开发用于 HBV/HIV 共感染研究的人源化转基因小鼠
- 批准号:
9882941 - 财政年份:2019
- 资助金额:
$ 4.2万 - 项目类别:
Development of Modular CRISPR Genome Editing Technologies and Tools
模块化CRISPR基因组编辑技术和工具的开发
- 批准号:
10202690 - 财政年份:2019
- 资助金额:
$ 4.2万 - 项目类别:
Development of Modular CRISPR Genome Editing Technologies and Tools
模块化CRISPR基因组编辑技术和工具的开发
- 批准号:
10666490 - 财政年份:2019
- 资助金额:
$ 4.2万 - 项目类别:
Development of Modular CRISPR Genome Editing Technologies and Tools
模块化CRISPR基因组编辑技术和工具的开发
- 批准号:
9815153 - 财政年份:2019
- 资助金额:
$ 4.2万 - 项目类别:
Development of Modular CRISPR Genome Editing Technologies and Tools
模块化CRISPR基因组编辑技术和工具的开发
- 批准号:
10448385 - 财政年份:2019
- 资助金额:
$ 4.2万 - 项目类别:
相似海外基金
Systems Lipidomics tools and resources for biomedical research; LIPID MAPS.
用于生物医学研究的系统脂质组学工具和资源;
- 批准号:
MR/Y000064/1 - 财政年份:2024
- 资助金额:
$ 4.2万 - 项目类别:
Research Grant
The Common Fund Knowledge Center (CFKC): providing scientifically valid knowledge from the Common Fund Data Ecosystem to a diverse biomedical research community.
共同基金知识中心(CFKC):从共同基金数据生态系统向多元化的生物医学研究社区提供科学有效的知识。
- 批准号:
10851461 - 财政年份:2023
- 资助金额:
$ 4.2万 - 项目类别:
1st year MSc (Interdisciplinary Biomedical Research). The student will be assigned to a PhD project prior to the 2nd year of study.
第一年理学硕士(跨学科生物医学研究)。
- 批准号:
2881457 - 财政年份:2023
- 资助金额:
$ 4.2万 - 项目类别:
Studentship
1st year MSc (Interdisciplinary Biomedical Research). The student will be assigned to a PhD project prior to the 2nd year of study.
第一年理学硕士(跨学科生物医学研究)。
- 批准号:
2881508 - 财政年份:2023
- 资助金额:
$ 4.2万 - 项目类别:
Studentship
1st year MSc (Interdisciplinary Biomedical Research). The student will be assigned to a PhD project prior to the 2nd year of study.
第一年理学硕士(跨学科生物医学研究)。
- 批准号:
2883713 - 财政年份:2023
- 资助金额:
$ 4.2万 - 项目类别:
Studentship
Training Biomedical Research Teams for Rigor and Reproducibility in Data Science
培训生物医学研究团队以确保数据科学的严谨性和可重复性
- 批准号:
10723223 - 财政年份:2023
- 资助金额:
$ 4.2万 - 项目类别:
1st year MSc (Interdisciplinary Biomedical Research). The student will be assigned to a PhD project prior to the 2nd year of study.
第一年理学硕士(跨学科生物医学研究)。
- 批准号:
2881331 - 财政年份:2023
- 资助金额:
$ 4.2万 - 项目类别:
Studentship
1st year MSc (Interdisciplinary Biomedical Research). The student will be assigned to a PhD project prior to the 2nd year of study.
第一年理学硕士(跨学科生物医学研究)。
- 批准号:
2881518 - 财政年份:2023
- 资助金额:
$ 4.2万 - 项目类别:
Studentship
Combining Separation, Digestion, and Ionization on a Mass Spectrometry Cartridge to Enable Biomedical Research on Proteoforms
在质谱柱上结合分离、消化和电离,以实现蛋白质形式的生物医学研究
- 批准号:
10637225 - 财政年份:2023
- 资助金额:
$ 4.2万 - 项目类别:














{{item.name}}会员




